Aclaris Therapeutics to Participate in Two June Healthcare Conferences
Provided By GlobeNewswire
Last update: May 28, 2025
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in June.
Read more at globenewswire.com
